The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.


Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Federal Reserve Balance Sheet Reduction: Brookings Research Outlines Possible Path Forward
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
9 Tips for Avoiding Tax Season Cyber Scams
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 



